Pathogenesis of Antiphospholipid Syndrome
|
|
- Cuthbert Thornton
- 6 years ago
- Views:
Transcription
1 La Sapienza Università di Roma Maggio 2016 Pathogenesis of Antiphospholipid Syndrome Guido Valesini
2 - The twin paradox - The Amalia paradox
3 HUGHES SYNDROME THROMBOSIS, ABORTION, CEREBRAL DISEASE, AND THE LUPUS ANTICOAGULANT G.R.V. HUGHES Br. Med. J. 1983; 287:
4 Clinical criteria 1. Vascular thrombosis 2. Pregnancy morbidity Laboratory criteria (present on two or more occasions, at least 12 weeks apart) Lupus anticoagulant Anticardiolipin (acl) antibody Anti-β2 glycoprotein-i antibody
5 Pathogenetic mechanisms mediated by apl THROMBOSIS FETAL LOSS..& more Several umet needs!
6 Pathogenetic mechanisms mediated by apl THROMBOSIS Most of the pathogenic mechanisms have been demonstrated using in vitro models In vivo models of thrombosis induced in mice have confirmed that apl are able to increase thrombus formation in the venous and arterial trees. Passive infusion of human apl IgG together with a small amount of LPS was shown to trigger clotting in the rat mesenteric microcirculation. - Pierangeli S. S. et al, Circulation Jankowski M. et al, Blood Fischetti F. et al, Blood 2005 FETAL LOSS association is supported by several epidemiological studies and by experimental models showing that passive transfer of apl IgG induces fetal loss and growth retardation in pregnant naive mice. - Meroni PL et al, Lupus 2010
7 THROMBOSIS Clotting formation mediated by apl apl interact with endothelial cells, primarily through binding of β2gpi on cell surfacei Meroni PL et al, Nat Rev Rheumatol 2011
8 Endothelial cells activation by anti-β2gpi antibodies β2gpi adheres to endothelial cell membranes: electrostatic interaction between the cationic phospholipid-binding site (domain V) and anionic structures, such as heparan sulfate, on the cell membrane; as a ligand for annexin A2; cell signaling that results in activation of NFκB or p38 MAPK or both; interaction of the β2gpi clusters with TLR2/TLR4 might be responsible for MyD88 and TRAF6-dependent signaling Meroni PL et al, Nat Rev Rheumatol 2011
9 Clotting formation mediated by apl apl upregulate tissue factor expression on endothelial cells and blood monocytes endothelial leukocyte adhesion, cytokine secretion and PGE2 synthesis
10 β2gpi mrna expression by human peripheral blood monocytes Monocytes synthesize b2-gpi β2gpi expression on cell surface of monocytes flow cytometric analysis β2gpi expression on monocytes is significantly increased in patients APS and correlates with tissue factor expression on monocytes
11 - monocytes are able to synthesize β2-gpi - patients with APS may have increased β2-gpi exposure on cell surface, which leads to persistently high monocyte tissue factor expression and consequently to - prothrombotic diathesis.
12 Clotting formation mediated by apl apl recognize phospholipid-binding proteins expressed on platelets apl binding potentiates platelet aggregation Meroni PL et al, Nat Rev Rheumatol 2011
13 Clotting formation mediated by apl apl interfere with plasma components of the coagulation cascade: - inhibiting anticoagulant activity, - affecting fibrinolysis, - displacing the binding of the natural anticoagulant annexin A5 to anionic structures
14 Peptide of β2gpi-domain I shares 88% identity with an epitope within the extracellular domain of human TLR4 Autoantibodies specific to the peptide in a high percentage of sera from patients with SLE and APS, but not in sera from healthy donors The Abs, trigger a TLR4 signaling cascade with consequent IRAK phosphorylation and NF-B translocation, promote VCAM expression on endothelial cells and TNF- release by monocytes, thus leading to a proinflammatory microenvironment.
15 FETAL LOSS In vitro studies showed that apl might induce a procoagulant state (several mechanisms) ability of the apl (anti- β2gpi) antibodies to disrupt the anticoagulant annexin A5 shield on trophoblast and endothelial cell monolayers Rand J e al, Lupus 2010 Proinflammatory mediators (complement, TNF, chemokines) have been shown to have a role in animal models of apl-induced fetal loss Meroni PL et al, Nat Rev Rheumatol 2011 Use of glucocorticoids?? No evidence to support the routine use of glucocorticoids Ruiz-Irastorza G et al, Lancet 2010
16 FETAL LOSS Another mechanism DEFECTIVE PLACENTATION β2gpi-dependent antibodies bind to human trophoblasts and affect several cell functions in vitro: cell injury apoptosis inhibition of proliferation and syncitia formation decreased production of human chorionic gonadotrophin defective secretion of growth factors Expression of β2gpi on trophoblast cell membranes placental tropism of anti-β2gpi antibodies β2gpi binds to exposed phosphatidylserine on the external cell membranes of trophoblasts undergoing syncitium formation Meroni PL et al, Nat Rev Rheumatol 2011
17 Pathogenetic mechanisms mediated by apl THROMBOSIS FETAL LOSS..& more Several umet needs!
18 TWO-HIT HYPOTHESIS A two hit hypothesis has been suggested to explain the clinical observation that thrombotic events occur only occasionally in spite of the persistent presence of apl.
19 Clotting formation mediated by apl Procoagulant and proinflammatory state (apl-mediated) is necessary but not sufficient for clotting TWO-HIT HYPOTHESIS Supporting this mechanism the administration of a small amount of LPS was required for human β2gpi-specific apl IgG to produce a thrombogenic effect in rat mesenteric microcirculation Fischetti F, et al. Blood 2005 FIRST HIT (apl) SECOND HIT: - Infections and recent surgery (stress) - Oxidative stress such as smoking - Complement activation seems to be necessary to clot formation in vivo Giannakopoulos B et al, NEJM 2013
20 FETAL LOSS The main pathogenetic mechanism intra-placental thrombosis impairment of maternal fetal blood exchange TWO-HIT HYPOTHESIS (with the single exception of the increased risk of venous thromboembolism during pregnancy) Passive infusion of IgG fractions with apl activity induces fetal loss in naive pregnant mice without necessarily requiring a second hit Meroni PL et al, Nat Rev Rheumatol 2011
21 INFECTIONS and APS Infectious triggers induction of transient antiphospholipid antibodies If microbes permanently colonize us role in the pathogenesis of APS? MICROBIOTA the collection of all microorganisms colonizing humans, necessary for normal host physiology One potential piece in the APS puzzle could be the contribution of commensal bacteria to the development and maintenance of autoreactive CD4+ T cells and autoantibodies In genetically predisposed individuals, the gut microbiota may drive the induction of anti-β2gpi antibodies by several mechanisms Ruff WE et al, Curr Rheumatol Rep 2015
22 GUT MICROBIOTA and APS 1. Gut commensal antigens recognized by mucosal DCs (phagocytosis after barrier disruption or apoptosis of intestinal epithelial cells) 2. Commensal-derived LPS, phospholipids and oxidative stress conformational change of β2gpi that exposes cryptic epitopes in domains I of β2gpi DCs take up unfolded β2gpi bounds to LPS via receptors (e.g., TLRs) 3. DCs present cross-reactive commensal and cryptic β2gpi antigens to CD4+ helper T cells that assist antigen-specific B cells via CD40 ligand (co-stimulatory receptors). B cells then secrete IgA/IgG in the mucosal lumen and in the systemic circulation. Ruff WE et al, Curr Rheumatol Rep 2015
23 The clinical spectrum of the antiphospholipid syndrome (APS) is not limited to vascular thrombosis or miscarriages but includes additional manifestations that cannot be explained solely by a thrombophilic state.
24 APS, NOT JUST THROMBOSIS & MISCARRIAGE G.R.V. Hughes, The Rheumatologist. Volume 10. N.2, 2016
25 «CRITERIA NON CRITERIA» APS, NOT JUST THROMBOSIS & MISCARRIAGE BRAIN BONE & JOINTS Migraine Stroke Bone fractures Seizures Avascular necrosis (AVN) Memory Loss Multiple Sclerosis SKIN Autonomic disturbance (Postural Orthostatic Tachycardia Syndrome-POTS) Livaedo reticularis Psychiatric disorders GI TRACT & LIVER KIDNEY Renal artery stenosis Microangiopathy Abdominal angina Budd-Chiari syndrome HELLP syndrome (in pregnancy women) G.R.V. Hughes, The Rheumatologist. Volume 10. N.2, 2016
26 WHY THE BRAIN? APS, NOT JUST THROMBOSIS & MISCARRIAGE Platelet activation Tissue factor induction Disruption of the annexin A5 anticoagulant shield Endothelial activation Alteration of the permeability of the blood-brain-barrier Direct binding to neuronal cell surface Possible cross-reactivity between anti-lymphocyte antibodies and brain G.R.V. Hughes, The Rheumatologist. Volume 10. N.2, 2016
27 APS, NOT JUST THROMBOSIS & MISCARRIAGE Anti-β2GPI might contribute to CNS pathology by either a direct interaction with astrocytes and neurons or an interaction with cerebral vascular endothelial cells Reverse transcriptase-polymerase chain reaction followed by restriction enzyme digestion of the product obtained demonstrated the presence of beta2-gpi mrna in endothelial cells, astrocytes and neurones
28 ANTIPHOSPHOLIPID ANTIBODIES Heterogeneous group of autoantibodies; Bind different anionic phospholipids, proteins or phospholipid-protein complex; a-cl a-factor-xii a-pth LAC??? a-lbpa a-β 2 -GPI a-pe a-sulfatides a-ps a-annexin-2 Valesini & Alessandri - Ann N Y Acad Sci, 2005
29 ANTIPHOSPHOLIPID ANTIBODIES Heterogeneous group of autoantibodies; Bind different anionic phospholipids, proteins or phospholipid-protein complex; a-cl a-factor-xii a-pth LAC??? a-lbpa a-β 2 -GPI a-pe a-sulfatides a-ps a-annexin-2 Valesini & Alessandri - Ann N Y Acad Sci, 2005
30 APL spectrum albpa aps ape LAC acl apth aβ2gpi af XII aanx A5 aanx 2..?
31 β2gpi: the playmaker in APS β2gpi circular form, with domain I interacting with domain V CRIPTIC EPITOPE hidden to the immune system Binding to an anionic phospholipid surface through domain V, the circular form of β2gpi opens up to a fishhook configuration exposing the domain I epitope Chighizola CB, Curr Rheumatol Rep 2014
32 Anti-β2GPI-domain I antibodies Anti-β2GPI-domain I antibodies the main apl pathogenic subset Patients with triple apl-positivity higher anti-b2gpi domain I antibody titres compared with double/single apl-positive patients The most recent studies have further confirmed the role of anti-domain I antibody positivity as a strong predictor of thrombotic events and pregnancy losses - Pengo V, et al. J Thromb Haemost Andreoli L, et al. Arthritis Rheumatol 2015
33 Time to challenge the dogma.. dominant thought
34 Many researchers propose that the only relevant antigens in the APS are the cofactors β2gpi the most important Antibodies binding phospholipids in a cofactor independent manner are considered insignificant for the pathogenesis of the APS REVIEW THIS EVIDENCE They don t negate a role for anti-β2gpi, but challenge the view that cofactor independent apl are irrelevant for the pathogenesis of the APS
35 Patients with the APS have quite heterogeneous antibody profiles. Contrary to common belief, there is ample evidence in the literature that a significant proportion if not the majority of APS patients harbor cofactor independent antibodies against cardiolipin.
36 Time to Challenge the Dogma Review of clinical studies: (1) LA is the apl test most consistently and strongly associated with thrombotic events (2) Anticardiolipin is still the immunoassay with the strongest and best documented association with thromboembolic events (3) None of the clinical studies was designed to differentiate between cofactor dependent and independent apl clinical data cannot support a pathophysiologic role of one or the other acl are pathogenic and this is independent of cofactor requirement the differentiation of pathogenic and non-pathogenic apl must be based on other criteria, not yet defined Lackner & Muller-Calleja, Journal of Thromb & Haemost 2016
37 .an «experimental model» in humans the so-called SERONEGATIVE APS
38 APS Clinical Spectrum PAPS, primary Microangiophatic APS SAPS, secondary Seronegative APS CAPS, cathastrophic GV, 2007
39 SERONEGATIVE APS Patients with clinical manifestations indicative of APS but persistently negative for the commonly used assays to detect apl Other autoantibodies? Other laboratory methods to detect apl? A new diagnostic tool: immunostaining on thin layer chromatography has been proposed to evaluate apl reactivity
40 SERONEGATIVE APS TLC immunostaining SN-APS pts=36 acl + in 47.2% of SN-APS albpa + in 41.7% of SN-APS ape + in 30.5% of SN-APS TLC immunostaining was performed with a second sample obtained at least 12 weeks later the same result was confirmed except in 5 sera: - 3 positive pts were negative; - 2 negative pts were positive. a representative TLC immunostaining with two positive and one negative samples Conti F, et al Clin Exp Immunol 2011
41 SERONEGATIVE APS Other results: IgG from SN-APS induce IRAK phosphorylation and NF-kB activation (a) IgG from SN-APS induce VCAM-1 surface expression and tissue factor release by endothelial cells (b) Conti F, et al Clin Exp Immunol 2011
42 We tested sera from patients with SN-APS by a proteomic approach, analysing endothelial cellsurface membrane proteins. Sera from SN-APS patients revealed two reactive spots, corresponding to vimentin, a protein which is shown to bind cardiolipin in vitro. TLC immunostaining SN-APS pts = 29 IgG anti-vimentin-cardiolipin in 55.2% IgM anti-vimentin-cardiolipin in 37.9% Confirmed in a second sample (after 12 weeks)
43 Affinity-purified antivimentin/cardiolipin antibodies from SN-APS induce: A) IRAK1 phosphorylation B) NF-kB activation in endothelial cells
44 SERONEGATIVE APS - small epidemiological weight - great conceptual value
45 Akwnoledgement DMISM Lupus Clinic Fabrizio Conti Cristiano Alessandri Francesca Spinelli Fulvia Ceccarelli Tania Colasanti Carlo Perricone Simona Truglia Francesca Miranda Laura Massaro Dipartimento Medicina Sperimentale Maurizio Sorice Roberta Misasi Antonella Capozzo Tina Garofalo Istituto Superiore Sanità Elena Ortona Paola Margutti
46
47
48 NEUTROPHILS and APS Like monocytes, circulating neutrophils from patients with APS are in an activated state their increased production of reactive ROS Effector function of neutrophils capacity to form extracellular traps (NETs) NETosis = a cell death process Figure by Valesini G et al, Autoimmun Rev 2015 NETosis is known to be impaired in SLE patients Recent studies indicate that NET formation and degradation are equally affected patients with PAPS Van den Hoogen, Autoimmun Rev 2015
49 NEUTROPHILS and PAPS Incubation of neutrophils from healthy controls with apl stimulates NET formation and also, that neutrophils from PAPS patients are more prone to undergo NETosis compared with neutrophils from healthy controls
50 NEUTROPHILS and SAPS/SLE Serum from both SLE and primary and secondary APS patients have a reduced capacity to degrade NETs which implies that these patients are strongly exposed to NETs Inhibition of NETosis targeting the inhibitory receptor SIRL-1 was recently proposed for SLE
51 COMPLEMENT ACTIVATION Case reports document the use of the C5 inhibitor eculizumab to prevent APS associated thrombotic microangiopathy that complicates renal transplantation to treat patients with acute CAPS Shapira I et al, Arthritis Rheum 2012 In vivo murine studies implicating the activation of the classical complement pathway in thrombosis associated with APS - Pierangeli SS et al, Arthr Rheum Fischetti F et al, Blood 2005 Activation of complement by apl generates C5a binds and activates neutrophils tissue factor expression Ritis K et al, J Immunol 2006
52 INNATE IMMUNE RESPONSE apl from patients with APS up-regulate the expression of TLR7 and TLR8 in plasmacytoid dendritic cells and in monocyte (respectively) and promote their translocation from the endoplasmic reticulum to the endosome Prinz N et al, Blood 2011 Inhibition of TLR7 and TLR8 may be an attractive therapeutic target in patients with SLE and apl antibodies HYDROXYCHLOROQUINE inhibits TLR7 Kuznik A et al, J Immunol 2011 B-cell activating factor (BAFF) is a cytokine crucial for B-cell survival BAFF inhibition prevented thrombosis in NZW x BXSB F1 male mice a role in the prevention of thrombosis associated with the APS in high-risk patients with SLE Kahn P et al, Arthritis Rheum 2008
53
54
55 Antiphospholpid antibodies in asymptomatic carriers
56 APS Classification Primary APS (53%) Secondary APS (47%) Secondary to Autoimmune Diseases
57 Citrullinazione e Artrite Reumatoide G. Valesini Felix qui potuit rerum cognoscere causas
58 LAC methods Step 1 activated Partial Thromboplastin Time (aptt); Dilute Russel viper venom time (drvvt); Kaolin clotting time (KCT); (LAC positive if 1 or more test prolungation) Step 2 Mixing test: mix (1:1) normal human plasma with Pts plasma (LAC positive if persist prolungation) Step 3 Neutralization test: add phospholipids or platelets to Pts plasma (LAC positive if the tests become normal)
59 - Classification of APS should be avoided if less than 12 weeks or more than 5 years separate the positive apl test and the clinical manifestation. - Coexisting inherited or acquired factors for thrombosis are not reasons for excluding patients from APS trials. - Superficial venous thrombosis is not included in the clinical criteria. 64
60 Peptide of β2gpi-domain I shares 88% identity with an epitope within the extracellular domain of human TLR4 Complete sequence omology between β2gpi and P.Gingivalis
61 β2gpi-domain I: immunodominant epitope Pathogenic effect of anti-domain I antibodies using anti-β2gpi minibody (MBB2) a human monoclonal IgG antibody -- targeting b2gpi domain I. Its infusion induced fetal losses in pregnant mice and blood clots in rat mesenteric microcirculation after LPS priming. MBB2DCH2 displays the same antigen specificity of MBB2, but lacks the CH2 domain, being unable to activate complement. Therapeutic implications: MBB2DCH2 has been shown to prevent apl effects in vivo by competing with autoantibodies for binding to b2gpi Agostinis C et al, Blood 2014
62 Oxidative stress and APS Paraoxonase activity (antioxidant properties) significantly decreased in APS pts Plasma levels of β2gpi-oxidized-ldl complexes are elevated in APS patients as compared with healthy controls Oxidative stress plays a direct role in the structure and function of β2gpi In healthy subjects, the free thiol form of β2gpi predominates in the plasma characterized by a broken disulfide bridge at Cys32 and Cys60 and at Cys288 andcys326 Under conditions of oxidative stress, disulfide bonds form at these sites unmask criptic epitope Giannakopoulos B et al, NEJM 2013
63 β2gpi: a bridge between circulating apl and target cells Second hit hypothesis VCAM-I, ICAM-I and E-selectine Del Papa N, 1997 Ab-specific peptide β2gpi cross-react with TLR4 Colasanti T, 2012 TF expression Conti F, 2003 β2gpi- Receptor (Annexin II) and Sorice via M, TLR Sherer Y, 2007 Platelets aggregatio n Asherson RA, 2007 Protein C Annexin V activation Meroni PL, 2004 Sherer Y, 2007 Modified from Meroni PL, Art Res & Therapy 2014
64 The phosphatidylinositol 3-kinase (PI3K) AKT pathway recently identified as an additional signalling cascade engaged by apls This pathway culminates in the recruitment of mammalian target of rapamycin (mtor), a kinase modulating cellular growth, proliferation and apoptosis.
65 Confirmed at immunostaining: the phosphorylation rate of both S6RP and AKT was markedly increased in vascular endothelial cells in renal specimens from APS patients with apl nephropathy and in the carotid and left anterior descending arteries of catastrophic APS mtor pathway might mediate the intimal hyperplasia leading to chronic vasculopathy mtor inhibitor SIROLIMUS was prescribed to patients with APS nephropathy undergoing kidney transplantation who developed no vascular lesion recurrence Canaud G. et al, NEJM 2014
66 A schematic overview of the most recent insights into the intracellular pathways engaged by anti-b2gp Chighizola CB et al, Curr Opin Rheumatol. 2015
67 FROM PATHOGENESIS TO TREATMENT Giannakopoulos B et al, NEJM 2013
68 Activation of NFκB or p38 MAPK The cellular steps leading to NF-kB translocation in monocytes have been recently clarified: apls engaged NF-kB via a clathrin-dependent endocytic pathway requiring CD14 (TLR4 co-receptor) and AnnexinA2 Brandt KJ et al, J.Thromb.Haemost 2014 NF-kB potential future pharmacological target: in BALB/c mice, treatment with a specific NF-kB inhibitor (Dehydroxymethylepoxyquinomicin), prevented apl-mediated thrombus formation Nishimura M et al, J Nephropathol 2013
69 FETAL LOSS Immunohistological analysis of abortive material or full-term placentae from APS women has not provided conclusive information about the pathogenic contributions of acute local inflammatory events and complement deposition lack of histological evidence of inflammation in the human placentae - Park, A. SpringerVerlag Gerosa, M. et al Ann Rheum Dis 2009 apl abnormalities at the maternal side of the placenta In endometrial biopsies impaired endometrial differentiation and reduced expression of complement decay-accelerating factor (CD55) were found These alterations before conception might compromise implantation and predispose to complement-mediated pregnancy failure Francis J et al, Mol Hum Reprod 2006
70 Non Criteria APS clinical manifetations Thrombocytopenia Heart valve disease Skin ( livedo, ulcers, superficial thrombophlebitis) Kidney ( renal Arterial stenosis, APS nephropathy) CNS Migraine/headache, Epilepsy, MS like disese, Cognitive impairment, Dementia, Transverse myelopathy, Retinal Thtombosis, Amaurosis fugax, Pulmonary alveolar hemorrhage
71 Criteria for pathogenicity of apl 1. Presence in many or most APS patients 2. Induction of humoral or cellular responses compatible with the clinical manifestation of the APS 3. Induction of clinical manifestations of the APS in vivo 4. Association with clinical manifestations of the APS in humans Lackner & Muller-Calleja, Journal of Thromb & Haemost 2016
72 McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2- glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990; 87: Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda- Vriesman PJ, Barbui T, Zwaal RF, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Sumida T, Yasuda T, Koike T. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148:
Thrombophilia. Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS
Autoimmune Thrombophilia Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS Saraf@sina.tums.ac.ir Acquired Thrombophilia HIT PNH Cyckle cell Anemia Myeloproliferative lf Diseases Thrombocytosis
More informationManifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria
Manifestation of Antiphospholipid Syndrome among Saudi patients :examining the applicability of sapporo Criteria Farjah H AlGahtani Associate professor,md,mph Leukemia,Lymphoma in adolescent,thromboembolic
More informationKey words: antiphospholipid syndrome, trombosis, pathogenesis
26. XI,. 4/2011,.,..,..,., -..,,. 2GPI. -,.,,., -,, -, -,,,,, IL-1, IL-2, IL-6, IL-8, IL-12, IL-10, TNF, INF-. :,, N. Stoilov, R. Rashkov and R. Stoilov. ANTIPHOSPHOLIPID SYNDROME HISTORICAL DATA, ETI-
More informationCurrent View of the Treatment of Antiphospholipid Syndrome
GROUPE HOSPITALIER PITIE SALPETRIERE Current View of the Treatment of Antiphospholipid Syndrome Pr Zahir AMOURA Department of Internal Medicine French National Reference center for SLE and APS Hôpital
More informationAnti β 2. -Glycoprotein I and Antiphosphatidylserine Antibodies Are Predictors of Arterial Thrombosis in Patients With Antiphospholipid Syndrome
Coagulation and Transfusion Medicine / PREDICTIVE VALUE OF ANTIPHOSPHOLIPID ANTIBODIES Anti β -Glycoprotein I and Antiphosphatidylserine Antibodies Are Predictors of Arterial Thrombosis in Patients With
More informationAll about Antiphospholipid Syndrome. M.B. Agarwal, MD Prof & Head, Dept of Haematology, Bombay Hospital Institute of Medical Sciences, Mumbai, India
All about Antiphospholipid Syndrome M.B. Agarwal, MD Prof & Head, Dept of Haematology, Bombay Hospital Institute of Medical Sciences, Mumbai, India 1 2 3 4 5 6 Antiphospholipid syndrome A study of 192
More informationSindrome da anticorpi antifosfolipidi: clinica e terapia. Vittorio Pengo Clinical Cardiology, Padova, Italy
Sindrome da anticorpi antifosfolipidi: clinica e terapia Vittorio Pengo Clinical Cardiology, Padova, Italy Revised Classification Criteria for the Antiphospholipid Syndrome J Thromb Haemost 2006;4:295-306
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationAntiphospholipid Syndrome ( APS)
Antiphospholipid Syndrome ( APS) Edward John Walter Bowie, MD Mayo Medical School the first to identify APS as an acquired thrombophilia Graham Robert Vivian Hughes MD FRCP Unit Rayne Institute St Thomas
More informationMohammadreza Tabatabaei IBTO COAG LAB
Tests for the Evaluation of Lupus Anticoagulants t Mohammadreza Tabatabaei MSc Hematology blood bank MSc Hematology blood bank IBTO COAG LAB Lupus Anticoagulants General Background Lupus anticoagulants
More informationDaniel Egan, MD April 13, 2012
Daniel Egan, MD April 13, 2012 Aug 2006 (at age 15): Acute unprovoked DVT in left common femoral vein Factor V Leiden heterozygous Positive lupus inhibitor Lovenox BID 2 weeks later: increased clot burden,
More informationThe Antiphospholipid Syndrome
The Antiphospholipid Syndrome 1 / 6 2 / 6 3 / 6 The Antiphospholipid Syndrome Antiphospholipid antibody syndrome (commonly called antiphospholipid syndrome or APS) is an autoimmune disease present mostly
More informationResearch Article The Mosaic of Seronegative Antiphospholipid Syndrome
Immunology Research, Article ID 389601, 7 pages http://dx.doi.org/10.1155/2014/389601 Research Article The Mosaic of Seronegative Antiphospholipid Syndrome Fabrizio Conti, 1 Antonella Capozzi, 2 Simona
More informationAntiphospholipid Syndrome Handbook
Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, Oier Ateka-Barrutia, and Munther A. Khamashta Antiphospholipid Syndrome Handbook Maria Laura Bertolaccini, MD, PhD Lupus Research Unit The Rayne
More informationLupus Anticoagulants (LA), Antiphospholipid (APL) Antibodies & APL Syndrome: Review & Update. Antiphospholipid. Antiphospholipid
, Antiphospholipid (APL) Antibodies & APL Syndrome: Review & Update William L. Nichols, MD Mayo Clinic College of Medicine Rochester, Minnesota USA Disclosures & Objectives (Nichols) Disclosures Relevant
More informationTECHNICAL SERIES. Lupus Anticoagulants: Basic Concepts and Laboratory Diagnosiss. ...Setting trends TULIP DIAGNOSTICS (P) LTD.
For the use of Registered Medical Practioners and Laboratories only TECHNICAL SERIES Lupus Anticoagulants: Basic Concepts and Laboratory Diagnosiss TULIP DIAGNOSTICS (P) LTD. Gitanjali, Tulip Block, Dr.
More informationAre there still any valid indications for thrombophilia screening in DVT?
Carotid artery stenosis and risk of stroke Are there still any valid indications for thrombophilia screening in DVT? Armando Mansilha MD, PhD, FEBVS Faculty of Medicine of University of Porto Munich, 2016
More informationAN INTERESTING CASE OF RESPIRATORY DISTRESS. Dr.V.Akila Devi DNB PG Southern Railway Headquarters Hospital Chennai
AN INTERESTING CASE OF RESPIRATORY DISTRESS Dr.V.Akila Devi DNB PG Southern Railway Headquarters Hospital Chennai 11 month old female infant 1 st born to parents of NC marriage referred from Kolkatta H/O:
More informationPrevalence of antiphospholipid auto antibodies in patients with thrombosis
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 6/ September 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Prevalence of antiphospholipid auto antibodies in patients
More informationHow the Innate Immune System Profiles Pathogens
How the Innate Immune System Profiles Pathogens Receptors on macrophages, neutrophils, dendritic cells for bacteria and viruses Broad specificity - Two main groups of bacteria: gram positive, gram-negative
More informationOverview of the immune system
Overview of the immune system Immune system Innate (nonspecific) 1 st line of defense Adaptive (specific) 2 nd line of defense Cellular components Humoral components Cellular components Humoral components
More informationAntiphospholipid Antibody Syndrome: Management Issues for the Hematologist
Antiphospholipid Antibody Syndrome: Management Issues for the Hematologist Wisconsin Institute of Discovery Karen Rossi/Bristol-Myers Squibb Morey A. Blinder, MD Washington University, St. Louis, MO March
More informationLupus as a risk factor for cardiovascular disease
Lupus as a risk factor for cardiovascular disease SØREN JACOBSEN Department Rheumatology, Rigshospitalet Søren Jacobsen Main sponsors: Gigtforeningen Novo Nordisk Fonden Rigshospitalet Disclaimer: Novo
More informationMedical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University
Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve
More information1. The scavenger receptor, CD36, functions as a coreceptor for which TLR? a. TLR ½ b. TLR 3 c. TLR 4 d. TLR 2/6
Allergy and Immunology Review Corner: Cellular and Molecular Immunology, 8th Edition By Abul K. Abbas, MBBS, Andrew H. H. Lichtman, MD, PhD and Shiv Pillai, MBBS, PhD. Chapter 4 (pages 62-74): Innate Immunity
More informationPROTEÓMICA y SAF. Maria Josė Cuadrado Lupus Research Unit St. Thomas Hospital London UK
PROTEÓMICA y SAF Maria Josė Cuadrado Lupus Research Unit St. Thomas Hospital London UK Aknowledgments Chary López-Pedrera Angeles Aguirre Francisco Velasco Hospital Reina Sofia, Córdoba, España Laura Bertolaccini
More informationT he antiphospholipid syndrome (APS) is a thrombophilic
1639 EXTENDED REPORT ntiphospholipid antibody tests: spreading the net M L ertolaccini, S Gomez, J F P Pareja, Theodoridou, G Sanna, G R V Hughes, M Khamashta... See end of article for authors affiliations...
More informationLa sindrome da apl : up to date
La sindrome da apl : up to date PL Meroni Div. of Rheumatology, Dept. Clinical Sciences & Community Health, Univ. of Milan, Ist. G Pini Milan Classification criteria for APS Vascular thrombosis: > 1 episode
More informationPrinciples of Adaptive Immunity
Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors
More informationThursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III
REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels
More informationImmune System AP SBI4UP
Immune System AP SBI4UP TYPES OF IMMUNITY INNATE IMMUNITY ACQUIRED IMMUNITY EXTERNAL DEFENCES INTERNAL DEFENCES HUMORAL RESPONSE Skin Phagocytic Cells CELL- MEDIATED RESPONSE Mucus layer Antimicrobial
More informationInnate Immunity. Chapter 3. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples. Antimicrobial peptide psoriasin
Chapter Know Differences and Provide Examples Innate Immunity kin and Epithelial Barriers Antimicrobial peptide psoriasin -Activity against Gram (-) E. coli Connection Between Innate and Adaptive Immunity
More informationReview. The future of treatment for antiphospholipid syndrome. Rohan Willis* 1, Eon Nigel Harris 2 & Silvia Pierangeli 1
The future of treatment for antiphospholipid syndrome Recurrent thrombosis and pregnancy morbidity are the clinical hallmarks of the antiphospholipid syndrome (APS) and occur in the presence of persistent
More informationCytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,
Cytokines http://highered.mcgraw-hill.com/sites/0072507470/student_view0/chapter22/animation the_immune_response.html Cytokines modulate the functional activities of individual cells and tissues both under
More informationPhysiology Unit 3. ADAPTIVE IMMUNITY The Specific Immune Response
Physiology Unit 3 ADAPTIVE IMMUNITY The Specific Immune Response In Physiology Today The Adaptive Arm of the Immune System Specific Immune Response Internal defense against a specific pathogen Acquired
More informationReview. Management of the antiphospholipid syndrome: new approaches
Review Management of the antiphospholipid syndrome: new approaches The antiphospholipid syndrome (APS) is an autoimmune, multisystemic disorder associated with recurrent thrombosis (arterial and/or venous)
More informationThe Adaptive Immune Responses
The Adaptive Immune Responses The two arms of the immune responses are; 1) the cell mediated, and 2) the humoral responses. In this chapter we will discuss the two responses in detail and we will start
More informationStructure and Function of Antigen Recognition Molecules
MICR2209 Structure and Function of Antigen Recognition Molecules Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will examine the major receptors used by cells of the innate and
More informationMOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism
MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism SCHMAIEL SHIRDEL CONTENT 2 Introduction Autoimmune diseases Classification Involved components Autoimmune
More informationAntiphospholipid Syndrome
Antiphospholipid Syndrome EliA Cardiolipin and EliA β2-glycoprotein I Fully Automated Testing for Antiphospholipid Syndrome (APS) Testing for APS according to classification criteria determination of anti-β2-glycoprotein
More informationSummary of the 11th International Congress on Antiphospholipid Antibodies, Sydney, Australia, November 2004
Journal of Reproductive Immunology 66 (2005) 85 90 Meeting report Summary of the 11th International Congress on Antiphospholipid Antibodies, Sydney, Australia, November 2004 The 11th International Congress
More informationAMPLIADO SÍNDROME ANTIFOSFOLÍPIDO SÍNDROME DE SJÖGREN María José Cuadrado Lozano Clínica Universidad de Navarra-Madrid
AMPLIADO SÍNDROME ANTIFOSFOLÍPIDO SÍNDROME DE SJÖGREN María José Cuadrado Lozano Clínica Universidad de Navarra-Madrid PLASMABLAST PROLIFERATION IS ASSOCIATED WITH TLR7 POLYMORPHISMS AND UPREGULATION OF
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationT-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:
Interactions between innate immunity & adaptive immunity What happens to T cells after they leave the thymus? Naïve T cells exit the thymus and enter the bloodstream. If they remain in the bloodstream,
More informationAntigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS
1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family
More informationCELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.
!! www.clutchprep.com CONCEPT: OVERVIEW OF HOST DEFENSES The human body contains three lines of against infectious agents (pathogens) 1. Mechanical and chemical boundaries (part of the innate immune system)
More informationKeywords: apl, Hughes syndrome, pregnancy loss, prothrombin, thrombosis. Introduction
Journal of Thrombosis and Haemostasis, 10: 2512 2518 DOI: 10.1111/jth.12014 ORIGINAL ARTICLE Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of
More information[AUTOIMMUNITY] July 14, 2013
This sheet includes only the extra notes. Slide 5,6: [AUTOIMMUNITY] July 14, 2013 Autoimmunity is the condition or case where the immune system is activated by self antigensand when the immune system no
More informationInnate Immunity. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples Chapter 3. Antimicrobial peptide psoriasin
Know Differences and Provide Examples Chapter * Innate Immunity * kin and Epithelial Barriers * Antimicrobial peptide psoriasin -Activity against Gram (-) E. coli Connection Between Innate and Adaptive
More informationRituximab. B Cell Inhibition in APS. Methods. B Cell Inhibition in APS. Disclosure 11/6/2011
Rituximab in Antiphospholipid Syndrome (RITAPS) A Pilot Open-Label Phase II Prospective Trial for Non-Criteria Manifestations of Antiphospholipid Antibodies (NCT: 00537290) Disclosure Research Support:
More informationImmunity. Acquired immunity differs from innate immunity in specificity & memory from 1 st exposure
Immunity (1) Non specific (innate) immunity (2) Specific (acquired) immunity Characters: (1) Non specific: does not need special recognition of the foreign cell. (2) Innate: does not need previous exposure.
More informationAntiphospholipid Antibody Testing: Which Are Most Useful for Diagnosis?
Rheum Dis Clin N Am 32 (2006) 455 463 Antiphospholipid Antibody Testing: Which Are Most Useful for Diagnosis? Maria Laura Bertolaccini, MD, PhD*, Graham R.V. Hughes, MD, FRCP Lupus Research Unit, The Rayne
More informationThrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI
Thrombophilia Diagnosis and Management Kevin P. Hubbard, DO, FACOI Clinical Professor of Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri
More informationI. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms. Table 2: Innate Immunity: First Lines of Defense
I. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms Table 2: Innate Immunity: First Lines of Defense Innate Immunity involves nonspecific physical & chemical barriers that are adapted for
More informationAntiphospholipid antibodies
CARDIOLOGY PATIENT PAGE CARDIOLOGY PATIENT PAGE Antiphospholipid Antibodies Caron P. Misita, PharmD; Stephan Moll, MD Antiphospholipid antibodies (APLAs) are proteins that may be present in the blood and
More information11/25/2017. THE IMMUNE SYSTEM Chapter 43 IMMUNITY INNATE IMMUNITY EXAMPLE IN INSECTS BARRIER DEFENSES INNATE IMMUNITY OF VERTEBRATES
THE IMMUNE SYSTEM Chapter 43 IMMUNITY INNATE IMMUNITY EXAMPLE IN INSECTS Exoskeleton made of chitin forms the first barrier to pathogens Digestive system is protected by a chitin-based barrier and lysozyme,
More informationImmunology for the Rheumatologist
Immunology for the Rheumatologist Rheumatologists frequently deal with the immune system gone awry, rarely studying normal immunology. This program is an overview and discussion of the function of the
More informationChapter 3 The Induced Responses of Innate Immunity
Chapter 3 The Induced Responses of Innate Immunity Pattern recognition by cells of the innate immune system Pattern recognition by cells of the innate immune system 4 main pattern recognition receptors
More informationThe Adaptive Immune Response. B-cells
The Adaptive Immune Response B-cells The innate immune system provides immediate protection. The adaptive response takes time to develop and is antigen specific. Activation of B and T lymphocytes Naive
More informationAnticardiolipin Antibodies in Patients With Type 2 Diabetes Mellitus
CM&R Rapid Release. Published online ahead of print February 26, 2009 as doi:10.3121/cmr.2008.828 Original Research Anticardiolipin Antibodies in Patients With Type 2 Diabetes Mellitus José María Calvo-Romero,
More informationAnaesthesiologic management of a parturient with a known antiphospholipid syndrome
Anaesthesiologic management of a parturient with a known antiphospholipid syndrome Pascal Vuilleumier Universitätsklinik für Anästhesie und Schmerztherapie Case presentation: Mrs A. B. 1975 Early monday
More informationAntiphospholipid Syndrome: It s Far More Than You Think
Antiphospholipid Syndrome: It s Far More Than You Think Richard Furie, MD Chief, Division of Rheumatology Northwell Health Professor of Medicine Zucker School of Medicine at Hofstra/Northwell Richard Furie,
More informationHIV AND INFLAMMATION: A NEW THREAT
HIV AND INFLAMMATION: A NEW THREAT KAP ANNUAL SCIENTIFIC CONFERENC MAY 2013 DR JOSEPH ALUOCH FRCP,EBS Basic Components of the Immune System Immunology: cells and tissues involved in recognizing and attacking
More informationTitle. CitationLupus, 21(14): Issue Date Doc URL. Rights. Type. File Information
Title Predominant prevalence of arterial thrombosis in Jap Fujieda, Yuichiro; Atsumi, Tatsuya; Amengual, Olga; Author(s) Yujiro; Horita, Tetsuya; Yasuda, Shinsuke; Koike, Ta CitationLupus, 21(14): 1506-1514
More informationNecrotizing Enterocolitis: The Role of the Immune System
Necrotizing Enterocolitis: The Role of the Immune System Patricia Denning, M.D. Associate Professor in Pediatrics Division of Neonatology Emory University School of Medicine What is NEC? What is NEC? Necrotizing
More informationAutoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic
Autoimmune Diseases Betsy Kirchner CNP The Cleveland Clinic Disclosures (financial) No relevant disclosures Learning Objectives Explain the pathophysiology of autoimmune disease Discuss safe administration
More informationT Cell Effector Mechanisms I: B cell Help & DTH
T Cell Effector Mechanisms I: B cell Help & DTH Ned Braunstein, MD The Major T Cell Subsets p56 lck + T cells γ δ ε ζ ζ p56 lck CD8+ T cells γ δ ε ζ ζ Cα Cβ Vα Vβ CD3 CD8 Cα Cβ Vα Vβ CD3 MHC II peptide
More informationIntroduction to Immunopathology
MICR2209 Introduction to Immunopathology Dr Allison Imrie 1 Allergy and Hypersensitivity Adaptive immune responses can sometimes be elicited by antigens not associated with infectious agents, and this
More informationInnate Immunity. By Dr. Gouse Mohiddin Shaik
Innate Immunity By Dr. Gouse Mohiddin Shaik Types of immunity Immunity Innate / inborn Non-specific Acquired / adaptive Specific 3rd line of defense Physical barriers Skin, Saliva, Mucous, Stomach acid,
More informationAll animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity
1 2 3 4 5 6 7 8 9 The Immune System All animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity Figure 43.2 In innate immunity, recognition and
More informationInnate vs Adaptive Response
General Immunology Innate vs Adaptive Response Innate- non-specific (4 types of barriers) anatomic- ato mechanical ca (skin), ph, mucous, normal flora Physiologic- temperature, ph, chemicals (lysozyme,
More informationTHROMBOPHILIA SCREENING
THROMBOPHILIA SCREENING Introduction The regulation of haemostasis Normally, when a clot occurs, it exactly occurs where it has to be and does not grow more than necessary due to the action of the haemostasis
More informationInnate immune regulation of T-helper (Th) cell homeostasis in the intestine
Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Masayuki Fukata, MD, Ph.D. Research Scientist II Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation,
More informationLupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome
Turk J Hematol 2007; 24:69-74 Turkish Society of Hematology RESEARCH ARTICLE Lupus anticoagulant and anticardiolipin antibodies in SLE with secondary Antiphospholipid Antibody Syndrome Shveta Garg, Annamma
More informationPD Dr. med. habil. Michaela Jaksch, Consultant Laboratory Medicine, Medical Director, Freiburg Medical Laboratory ME LLC, Dubai, UAE
Autoimmune Disorders in Gynecology/Obstetrics PD Dr. med. habil. Michaela Jaksch, Consultant Laboratory Medicine, Medical Director, Freiburg Medical Laboratory ME LLC, Dubai, UAE Abstract The spectrum
More informationThrombophilia: To test or not to test
Kenneth Bauer, MD Harvard Medical School, Boston, MA Professor of Medicine VA Boston Healthcare System Chief, Hematology Section Beth Israel Deaconess Medical Center, Boston, MA Director, Thrombosis Clinical
More informationPS + MPs PS - MPs 37% 36% 64% 64%
Supplementary Figure 1. Amount and distribution of phosphatidylserine negative (PS - ) and phosphatidylserine positive (PS + ) MPs in 280 SLE patients and 280 controls. Circles are proportional to the
More informationCIC Edizioni Internazionali. Cardio-metabolic comorbidities in rheumatoid arthritis and SLE. Review. 120 Clinical Dermatology 2013; 1 (2):
Review Cardio-metabolic comorbidities in rheumatoid arthritis and SLE Andrea Doria Division of Rheumatology University of Padua, Italy Address for correspondence: Division of Rheumatology University of
More informationJournal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients
S a m m i M o n t a g F i s h O i l E m u l s i o n J o u r n a l C l u b - P a g e 1 Journal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients Introduction/Background I. Surgical
More informationChapter 3, Part A (Pages 37-45): Leukocyte Migration into Tissues
Allergy and Immunology Review Corner: Chapter 3, Part A (pages 37-45) of Cellular and Molecular Immunology (Seventh Edition), by Abul K. Abbas, Andrew H. Lichtman and Shiv Pillai. Chapter 3, Part A (Pages
More informationGenetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD
Advances in the Pathogenesis of IBD: Genetics Leads to Function Pathogenesis of IBD Environmental Factors Microbes Scott Plevy, MD Associate Professor of Medicine, Microbiology & Immunology UNC School
More informationHemolytic uremic syndrome: Investigations and management
Hemolytic uremic syndrome: Investigations and management SAWAI Toshihiro M.D., Ph.D. Department of Pediatrics, Shiga University of Medical Science Otsu, JAPAN AGENDA TMA; Thrombotic micro angiopathy STEC-HUS;
More informationAvailable Online at CODEN: IJRSFP (USA) Vol. 9, Issue, 3(L), pp , March, 2018.
ISSN: 0976-3031 Available Online at http://www.recentscientific.com CODEN: IJRSFP (USA) International Journal of Recent Scientific Research Vol. 9, Issue, 3(L), pp. 25504-25508, March, 2018 Research Article
More informationThe Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep
The Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep invaders out of the body (pp. 772 773; Fig. 21.1; Table
More informationAntiphospholipid antibodies are a heterogeneous family
Seasonal Distribution of Antiphospholipid Antibodies Thanh-Ha Luong, MD; Jacob H. Rand, MD; Xiao-Xuan Wu, MD; James H. Godbold, PhD; Mayra Gascon-Lema, MS; Stanley Tuhrim, MD Background and Purpose The
More information1. Overview of Adaptive Immunity
Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive
More informationInnate Immunity. Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 2 August 2016
Innate Immunity Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 2 August 2016 Objectives: Explain how innate immune system recognizes foreign substances
More informationAdaptive Immunity: Humoral Immune Responses
MICR2209 Adaptive Immunity: Humoral Immune Responses Dr Allison Imrie 1 Synopsis: In this lecture we will review the different mechanisms which constitute the humoral immune response, and examine the antibody
More informationn BASIC-TRANSLATIONAL REVIEW
n BASIC-TRANSLATIONAL REVIEW At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases April Barnado,*,1 Leslie J. Crofford,* and Jim C. Oates
More informationAntiphospholipid antibodies in patients with venous thrombosis at Kenyatta National Hospital
Research article Department of Human Pathology, School of Medicine, University of Nairobi, P. O. Box 19676 00202, Nairobi, Kenya Corresponding author: Dr KA Barasa, Department of Human Pathology, School
More informationORIGINAL PAPERS. Marek Cieśla 1, B D, Ewa Wypasek 1, 2, B D 1, 2, A, E, F. Abstract
ORIGINAL PAPERS Adv Clin Exp Med 2014, 23, 5, 729 733 ISSN 1899 5276 Copyright by Wroclaw Medical University Marek Cieśla 1, B D, Ewa Wypasek 1, 2, B D 1, 2, A, E, F, Anetta Undas IgA Antiphospholipid
More informationThe Innate Immune Response
The Innate Immune Response FUNCTIONS OF THE IMMUNE SYSTEM: Recognize, destroy and clear a diversity of pathogens. Initiate tissue and wound healing processes. Recognize and clear damaged self components.
More informationEffector T Cells and
1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New
More informationThird line of Defense
Chapter 15 Specific Immunity and Immunization Topics -3 rd of Defense - B cells - T cells - Specific Immunities Third line of Defense Specific immunity is a complex interaction of immune cells (leukocytes)
More informationNewly Recognized Components of the Innate Immune System
Newly Recognized Components of the Innate Immune System NOD Proteins: Intracellular Peptidoglycan Sensors NOD-1 NOD-2 Nod Protein LRR; Ligand Recognition CARD RICK I-κB p50 p65 NF-κB Polymorphisms in Nod-2
More informationThe term complement refers to the ability of a system of some nonspecific proteins in normal human serum to complement, i.e., augment the effects of
COMPLEMENT SYSTEM The term complement refers to the ability of a system of some nonspecific proteins in normal human serum to complement, i.e., augment the effects of other components of immune system,
More informationاالستاذ المساعد الدكتور خالد ياسين الزاملي \مناعة \المرحلة الثانية \ التحليالت المرضية \ المعهد التقني كوت
Complement System The term complement refers to the ability of a system of some nonspecific proteins in normal human serum to complement, i.e., augment the effects of other components of immune system,
More informationAutoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens
Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly
More informationSubject Index. Bcl-2, apoptosis regulation Bone marrow, polymorphonuclear neutrophil release 24, 26
Subject Index A1, apoptosis regulation 217, 218 Adaptive immunity, polymorphonuclear neutrophil role 31 33 Angiogenesis cancer 178 endometrium remodeling 172 HIV Tat induction mechanism 176 inflammatory
More informationInteractive Case Vignette: DOACs (Direct Oral Anti-Coagulants) vs. Warfarin for APLA (Anti-Phospholipid Antibody Syndrome)
Interactive Case Vignette: DOACs (Direct Oral Anti-Coagulants) vs. Warfarin for APLA (Anti-Phospholipid Antibody Syndrome) Ara Metjian, MD Duke Debates Benign Hematologic Highlights April 22, 2017 Disclaimer
More information